Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs. Wang H, Yuan S, Zheng Q, Zhang S, et al. Gastroenterology 2024;166:1130-1144.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wang H, Yuan S, Zheng Q, Zhang S, et al. Dual Inhibition of CDK4/6 and XPO1 Induces Senescence With Acquired Vulnerability to CRBN-Based PROTAC Drugs. Gastroenterology 2024;166:1130-1144.
PMID: 38262581